Showing results (1791-1800 of 1,933) with videos related to
Sort By:
Pageof 194
Open Heart|November 27, 2023
Differences in risk and costs between prehospital identified low-risk men and women with chest painGoaris W A Aarts, Cyril Camaro, Laura Rodwell, et al.Structural Heart : the Journal of the Heart Team|March 20, 2026
Different Types of Aortic Valve Stenosis in Patients Undergoing Transcatheter Aortic Valve ReplacementKimberley I Hemelrijk, Hugo M Aarts, Gijs M Broeze, et al.Journal of the American Heart Association|August 27, 2024
Cerebrovascular Events in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Pooled Patient-Level StudyAstrid C van Nieuwkerk, Hugo M Aarts, Kimberley I Hemelrijk, et al.Oncology|August 30, 2017
Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor ProphylaxisMaureen J Aarts, Birgit E Vriens, Maaike de Boer, et al.BMC Neurology|January 13, 2024
Don't be late! Timely identification of cognitive impairment in people with multiple sclerosis: a study protocolPauline T Waskowiak, Brigit A de Jong, Bernard M J Uitdehaag, et al.JAMA Oncology|December 6, 2016
Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer: The ROPETAR Randomized Clinical TrialGeert A Cirkel, Paul Hamberg, Stefan Sleijfer, et al.JACC. Cardiovascular Interventions|December 27, 2023
Bleeding in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Incidence, Trends, Clinical Outcomes, and PredictorsAstrid C van Nieuwkerk, Hugo M Aarts, Kimberley I Hemelrijk, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2020
Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular CancerJoost M Blok, Harmke J Groot, Eline H Huele, et al.The Prostate|September 23, 2015
Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relationSushil K Badrising, Vincent van der Noort, Alfons J M van den Eertwegh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer PatientsIris J H van Vlodrop, Sophie C Joosten, Tim De Meyer, et al.Pageof 194